Dopamine agonist withdrawal syndrome associated factors: A retrospective chart review

Dopamine agonist withdrawal syndrome (DAWS) has been introduced to describe the constellation of symptoms resulting from reduction or suspension of dopamine agonist medications. In patients with Parkinson’s disease (PD) the impact of DAWS can be significant in terms of distress and disability. Unfor...

Full description

Bibliographic Details
Main Authors: Xiomara Garcia, Mohammad Edrees Mohammad, Shnehal Patel, Xin Xin Yu, Hubert H. Fernandez
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Clinical Parkinsonism & Related Disorders
Online Access:http://www.sciencedirect.com/science/article/pii/S259011252200024X